Below is a comprehensive archive of press releases from MSF-USA. Use the options in the boxes below to filter results based on your preferences.

Topic

May 25, 2017

Ahead of the G7 summit that’s starting tomorrow in Italy, the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) is urging participating countries to address high medicine prices and drug-resistant infections, which affect people everywhere. Today, across the G7, countries are struggling to pay for new medicines to treat life-threatening illnesses like hepatitis C.

May 16, 2017

The US government on Monday announced that the so-called “Global Gag Rule” on abortion will now include all global health assistance programs, a decision that could have devastating effects on women and children all over the world and halt decades of progress on global health, said the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) today.

April 26, 2017

The current outbreak of hepatitis E in Diffa, Niger, highlights the poor water and sanitation conditions in which the vast majority of the displaced people and refugees in the region are living.

April 06, 2017

Less than a year after the official end of the Ebola outbreak, the Guinean health system continues to struggle.

March 27, 2017

First patent opposition MSF has filed in Europe aims to increase affordable access to hepatitis C drug sofosbuvir for millions

NEW YORK/ROME/GENEVA, MARCH 27, 2017—In an effort to increase access to affordable hepatitis C treatment, the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) filed a patent challenge on the lifesaving hepatitis C drug sofosbuvir with the European Patent Office (EPO) today.

February 14, 2017

NEW YORK/NEW DELHI, FEBRUARY 14, 2017—Five new challenges against flawed patents on crucial new medicines to treat hepatitis C filed in India and Argentina are the latest in a global push to ensure access to affordable treatment. The patent challenges could remove barriers to production and distribution of affordable generic versions of direct-acting antiviral (DAA) medicines, including sofosbuvir, daclatasvir and velpatasvir, and increase access for millions of people.

February 08, 2017

NEW YORK/N’AJAMENA, CHAD, FEBRUARY 9, 2017—A hepatitis E outbreak is escalating across Am Timan, in the Salamat region of South-Eastern Chad, and more humanitarian actors are urgently needed to treat patients and contain further spread of the virus, the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) said today.

January 25, 2017

NEW YORK, JANUARY 25, 2017—The reinstatement of the US government’s Mexico City Policy by President Donald J. Trump, which prohibits nongovernmental organizations that receive US funding from either performing or providing counseling or information on abortion, will undermine access to safe abortion services and endanger the lives of women, said Doctors Without Borders/Médecins Sans Frontières (MSF) Wednesday.

September 16, 2016

"The sustainable development goals (SDGs) adopted with much fanfare just a year ago seek to end HIV, tuberculosis, and malaria by 2030. The replenishment of the Global Fund is the first concrete action taken by the international community since the adoption of these goals, and therefore a first test of the world leaders' will to make them a reality. Failure to reach the relatively modest Global Fund's replenishment target would be a clear message that the SDGs were but empty promises to the millions who, every year, continue to suffer and die from HIV, tuberculosis, and malaria."

September 14, 2016

New report exposes pharmaceutical industry failings and highlights new ways of researching and developing medicines that address public health needs.

Pages